

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.30309194 |
| 2 | viral transcription (GO:0019083) | 5.02876793 |
| 3 | DNA deamination (GO:0045006) | 4.96182996 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.86012985 |
| 5 | translational termination (GO:0006415) | 4.85400188 |
| 6 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.77881619 |
| 7 | DNA unwinding involved in DNA replication (GO:0006268) | 4.75382080 |
| 8 | DNA strand elongation (GO:0022616) | 4.56838539 |
| 9 | translational elongation (GO:0006414) | 4.45675591 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 4.44602887 |
| 11 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.42427031 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.35024847 |
| 13 | DNA replication initiation (GO:0006270) | 4.28339067 |
| 14 | formation of translation preinitiation complex (GO:0001731) | 4.15684669 |
| 15 | ribosomal small subunit biogenesis (GO:0042274) | 4.13302181 |
| 16 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.13209176 |
| 17 | NIK/NF-kappaB signaling (GO:0038061) | 4.10829592 |
| 18 | translational initiation (GO:0006413) | 4.09636493 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.01310868 |
| 20 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.95244022 |
| 21 | ribosomal large subunit biogenesis (GO:0042273) | 3.90793911 |
| 22 | cotranslational protein targeting to membrane (GO:0006613) | 3.84639163 |
| 23 | protein targeting to ER (GO:0045047) | 3.84031737 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.81334444 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.81334444 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.81334444 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 3.81334444 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.81334444 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.81334444 |
| 30 | viral life cycle (GO:0019058) | 3.79452049 |
| 31 | cellular protein complex disassembly (GO:0043624) | 3.78945335 |
| 32 | response to peptidoglycan (GO:0032494) | 3.76721551 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.74712045 |
| 34 | telomere maintenance via recombination (GO:0000722) | 3.74443366 |
| 35 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.74000146 |
| 36 | protein localization to kinetochore (GO:0034501) | 3.73622446 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71903168 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.71558174 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.71558174 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.71455868 |
| 41 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.64723234 |
| 42 | regulation of mast cell degranulation (GO:0043304) | 3.63535306 |
| 43 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.61254675 |
| 44 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.59934612 |
| 45 | detection of bacterium (GO:0016045) | 3.59560129 |
| 46 | telomere maintenance via telomere lengthening (GO:0010833) | 3.59259885 |
| 47 | protein localization to endoplasmic reticulum (GO:0070972) | 3.58287841 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.54024317 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.50906791 |
| 50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.50074027 |
| 51 | mitotic recombination (GO:0006312) | 3.50056377 |
| 52 | protein complex disassembly (GO:0043241) | 3.49057304 |
| 53 | detection of other organism (GO:0098543) | 3.48236454 |
| 54 | regulation of mitotic spindle organization (GO:0060236) | 3.47218362 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 3.44597592 |
| 56 | mitotic sister chromatid segregation (GO:0000070) | 3.41566680 |
| 57 | regulation of spindle organization (GO:0090224) | 3.41347851 |
| 58 | positive thymic T cell selection (GO:0045059) | 3.41152226 |
| 59 | ribosome biogenesis (GO:0042254) | 3.41027977 |
| 60 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.40492261 |
| 61 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.38684722 |
| 62 | B cell receptor signaling pathway (GO:0050853) | 3.38069393 |
| 63 | nucleobase biosynthetic process (GO:0046112) | 3.37998673 |
| 64 | mitotic nuclear envelope disassembly (GO:0007077) | 3.35996300 |
| 65 | DNA replication checkpoint (GO:0000076) | 3.34502001 |
| 66 | protein localization to chromosome, centromeric region (GO:0071459) | 3.32057248 |
| 67 | pinocytosis (GO:0006907) | 3.31177651 |
| 68 | leukocyte aggregation (GO:0070486) | 3.30510970 |
| 69 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.29492199 |
| 70 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.27510859 |
| 71 | mitotic metaphase plate congression (GO:0007080) | 3.26417996 |
| 72 | negative regulation of RNA splicing (GO:0033119) | 3.24109933 |
| 73 | macromolecular complex disassembly (GO:0032984) | 3.24074026 |
| 74 | mannose metabolic process (GO:0006013) | 3.22980016 |
| 75 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.22538978 |
| 76 | regulation of leukocyte degranulation (GO:0043300) | 3.21295152 |
| 77 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.20394721 |
| 78 | pentose-phosphate shunt (GO:0006098) | 3.17058962 |
| 79 | regulation of translational fidelity (GO:0006450) | 3.16981480 |
| 80 | rRNA processing (GO:0006364) | 3.15392118 |
| 81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.13615069 |
| 82 | IMP biosynthetic process (GO:0006188) | 3.13476747 |
| 83 | membrane disassembly (GO:0030397) | 3.12606918 |
| 84 | nuclear envelope disassembly (GO:0051081) | 3.12606918 |
| 85 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.12297733 |
| 86 | thymic T cell selection (GO:0045061) | 3.10325428 |
| 87 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.09118733 |
| 88 | mRNA catabolic process (GO:0006402) | 3.06468613 |
| 89 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.06458012 |
| 90 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.06458012 |
| 91 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.06123892 |
| 92 | RNA catabolic process (GO:0006401) | 3.05260402 |
| 93 | tolerance induction (GO:0002507) | 3.03745611 |
| 94 | rRNA metabolic process (GO:0016072) | 3.03596392 |
| 95 | DNA duplex unwinding (GO:0032508) | 3.02528164 |
| 96 | regulation of gamma-delta T cell activation (GO:0046643) | 3.01348221 |
| 97 | macrophage activation involved in immune response (GO:0002281) | 3.01193387 |
| 98 | DNA geometric change (GO:0032392) | 3.00353933 |
| 99 | negative thymic T cell selection (GO:0045060) | 2.99944683 |
| 100 | deoxyribonucleotide catabolic process (GO:0009264) | 2.97462815 |
| 101 | negative regulation of mRNA processing (GO:0050686) | 2.97392426 |
| 102 | spliceosomal snRNP assembly (GO:0000387) | 2.97384014 |
| 103 | metaphase plate congression (GO:0051310) | 2.97092996 |
| 104 | sister chromatid segregation (GO:0000819) | 2.96654860 |
| 105 | response to muramyl dipeptide (GO:0032495) | 2.95906504 |
| 106 | pseudouridine synthesis (GO:0001522) | 2.95441531 |
| 107 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.92115219 |
| 108 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.90937248 |
| 109 | purine nucleobase biosynthetic process (GO:0009113) | 2.90870352 |
| 110 | modulation by symbiont of host cellular process (GO:0044068) | 2.90806137 |
| 111 | translation (GO:0006412) | 2.90404902 |
| 112 | IMP metabolic process (GO:0046040) | 2.89935401 |
| 113 | ribosome assembly (GO:0042255) | 2.89889958 |
| 114 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.89476470 |
| 115 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.89476470 |
| 116 | modulation by virus of host process (GO:0019054) | 2.88743235 |
| 117 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.88532648 |
| 118 | heterochromatin organization (GO:0070828) | 2.88085830 |
| 119 | termination of RNA polymerase II transcription (GO:0006369) | 2.86735907 |
| 120 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.85641083 |
| 121 | base-excision repair (GO:0006284) | 2.84977250 |
| 122 | germinal center formation (GO:0002467) | 2.84720932 |
| 123 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.83586624 |
| 124 | regulation of B cell differentiation (GO:0045577) | 2.83351717 |
| 125 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83324595 |
| 126 | negative regulation of chromosome segregation (GO:0051985) | 2.83108431 |
| 127 | myeloid dendritic cell activation (GO:0001773) | 2.83040506 |
| 128 | B cell mediated immunity (GO:0019724) | 2.82949393 |
| 129 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.82364332 |
| 130 | negative regulation of interleukin-12 production (GO:0032695) | 2.82280224 |
| 131 | deoxyribose phosphate catabolic process (GO:0046386) | 2.81742705 |
| 132 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81297545 |
| 133 | kinetochore organization (GO:0051383) | 2.79629315 |
| 134 | response to protozoan (GO:0001562) | 2.78623538 |
| 135 | T cell selection (GO:0045058) | 2.76909069 |
| 136 | type I interferon signaling pathway (GO:0060337) | 2.75928861 |
| 137 | cellular response to type I interferon (GO:0071357) | 2.75928861 |
| 138 | response to type I interferon (GO:0034340) | 2.75364779 |
| 139 | detection of external biotic stimulus (GO:0098581) | 2.73854236 |
| 140 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.73022887 |
| 141 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.72662873 |
| 142 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72335305 |
| 143 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.72173538 |
| 144 | negative T cell selection (GO:0043383) | 2.71875672 |
| 145 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71235193 |
| 146 | mRNA splicing, via spliceosome (GO:0000398) | 2.69219765 |
| 147 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.69219765 |
| 148 | negative regulation of innate immune response (GO:0045824) | 2.68882066 |
| 149 | kinetochore assembly (GO:0051382) | 2.68783790 |
| 150 | mitochondrial DNA metabolic process (GO:0032042) | 2.68538133 |
| 151 | defense response to protozoan (GO:0042832) | 2.68121614 |
| 152 | RNA splicing, via transesterification reactions (GO:0000375) | 2.68066596 |
| 153 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.67805484 |
| 154 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.67805484 |
| 155 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.67805484 |
| 156 | negative regulation of sister chromatid segregation (GO:0033046) | 2.67805484 |
| 157 | mitotic chromosome condensation (GO:0007076) | 2.67710300 |
| 158 | regulation of histone H3-K9 methylation (GO:0051570) | 2.67369862 |
| 159 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.67325010 |
| 160 | regulation of gene silencing by miRNA (GO:0060964) | 2.67325010 |
| 161 | regulation of gene silencing by RNA (GO:0060966) | 2.67325010 |
| 162 | mitotic spindle assembly checkpoint (GO:0007094) | 2.67295698 |
| 163 | regulation of antigen processing and presentation (GO:0002577) | 2.66722080 |
| 164 | response to thyroid hormone (GO:0097066) | 2.65786537 |
| 165 | telomere organization (GO:0032200) | 2.64536707 |
| 166 | DNA damage response, detection of DNA damage (GO:0042769) | 2.64467393 |
| 167 | spindle assembly checkpoint (GO:0071173) | 2.64371287 |
| 168 | establishment of chromosome localization (GO:0051303) | 2.63928159 |
| 169 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.63490841 |
| 170 | NADPH regeneration (GO:0006740) | 2.63447170 |
| 171 | myeloid dendritic cell differentiation (GO:0043011) | 2.63239683 |
| 172 | regulation of chromosome segregation (GO:0051983) | 2.62199473 |
| 173 | translesion synthesis (GO:0019985) | 2.62158315 |
| 174 | chromatin remodeling at centromere (GO:0031055) | 2.62017854 |
| 175 | telomere maintenance (GO:0000723) | 2.61232578 |
| 176 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.61028012 |
| 177 | response to host immune response (GO:0052572) | 2.61028012 |
| 178 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.60770626 |
| 179 | positive regulation of chromosome segregation (GO:0051984) | 2.60480019 |
| 180 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60188238 |
| 181 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57255491 |
| 182 | positive regulation of chemokine secretion (GO:0090197) | 2.56047966 |
| 183 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56021571 |
| 184 | positive regulation of mast cell degranulation (GO:0043306) | 2.56021571 |
| 185 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.55993169 |
| 186 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.55082679 |
| 187 | B cell homeostasis (GO:0001782) | 2.55067481 |
| 188 | response to host (GO:0075136) | 2.54558534 |
| 189 | response to host defenses (GO:0052200) | 2.54558534 |
| 190 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.54558534 |
| 191 | T cell migration (GO:0072678) | 2.54442042 |
| 192 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.53914469 |
| 193 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.53853349 |
| 194 | regulation of regulated secretory pathway (GO:1903305) | 2.48711064 |
| 195 | regulation of superoxide anion generation (GO:0032928) | 2.48696307 |
| 196 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.48029715 |
| 197 | positive regulation of mast cell activation (GO:0033005) | 2.47589753 |
| 198 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.47577167 |
| 199 | glucose catabolic process (GO:0006007) | 2.47267907 |
| 200 | negative regulation of phagocytosis (GO:0050765) | 2.47218377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.86510710 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.97755943 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.86473586 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.84866348 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.87581793 |
| 6 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.85180852 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.74538879 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.67169243 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.66073678 |
| 10 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.49852533 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.38019758 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.34905759 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.31201974 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.24820920 |
| 15 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.22915370 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.22382370 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.21949924 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.12132404 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11901104 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.10246785 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05871521 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.03052736 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02771715 |
| 24 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.02708539 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.02271391 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00588554 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.97926429 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88653140 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88139616 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83373573 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.83367706 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83265178 |
| 33 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.82696130 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.80491138 |
| 35 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.79029298 |
| 36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.77964359 |
| 37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72449735 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67457117 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66365166 |
| 40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.65582315 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.65081712 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.64593502 |
| 43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63767862 |
| 44 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63512190 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62766003 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62147566 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60706030 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59554729 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58964251 |
| 50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.57493253 |
| 51 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.57409896 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57241832 |
| 53 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.56602073 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56287875 |
| 55 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.55892346 |
| 56 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.55723068 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55573995 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.55358185 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52560160 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52288966 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52160423 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.51776698 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51157025 |
| 64 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51033831 |
| 65 | * P68_20966046_ChIP-Seq_HELA_Human | 1.50687034 |
| 66 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.50058337 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49958540 |
| 68 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.49528689 |
| 69 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.49411021 |
| 70 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.49204743 |
| 71 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.49184182 |
| 72 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.47465572 |
| 73 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.47015523 |
| 74 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.46880913 |
| 75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45679995 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42146696 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41624237 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.39667081 |
| 79 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38615433 |
| 80 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38175414 |
| 81 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.37380694 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35615731 |
| 83 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.35487692 |
| 84 | MYB_26560356_Chip-Seq_TH1_Human | 1.34103183 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32092863 |
| 86 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31304454 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30710401 |
| 88 | MYB_26560356_Chip-Seq_TH2_Human | 1.30677485 |
| 89 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29629289 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29540524 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27067314 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26939025 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26376913 |
| 94 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.26257793 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25691547 |
| 96 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.25608758 |
| 97 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25380437 |
| 98 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.24923890 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.23962721 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22928959 |
| 101 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21591199 |
| 102 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18562858 |
| 103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18344900 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17088747 |
| 105 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16935821 |
| 106 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16915983 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.14649584 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14533421 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14469996 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13746789 |
| 111 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12601936 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11911803 |
| 113 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11134526 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11081499 |
| 115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10605141 |
| 116 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09200771 |
| 117 | MAF_26560356_Chip-Seq_TH1_Human | 1.09145173 |
| 118 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08640596 |
| 119 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.07457252 |
| 120 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.06967394 |
| 121 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06521564 |
| 122 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06363121 |
| 123 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.06295034 |
| 124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06086804 |
| 125 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05708864 |
| 126 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.05510886 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05138899 |
| 128 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04352105 |
| 129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04192647 |
| 130 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03993884 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03433166 |
| 132 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03056372 |
| 133 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02799507 |
| 134 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02348005 |
| 135 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.01908857 |
| 136 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00539679 |
| 137 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00184971 |
| 138 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00047690 |
| 139 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99893132 |
| 140 | MAF_26560356_Chip-Seq_TH2_Human | 0.99277099 |
| 141 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98982327 |
| 142 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98975684 |
| 143 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98975406 |
| 144 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98859662 |
| 145 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98670728 |
| 146 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98410214 |
| 147 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98142696 |
| 148 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97562140 |
| 149 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.97313526 |
| 150 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.97313526 |
| 151 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.97313526 |
| 152 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96287954 |
| 153 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94523503 |
| 154 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94510706 |
| 155 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93824405 |
| 156 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93464918 |
| 157 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93434353 |
| 158 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93416250 |
| 159 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92205664 |
| 160 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91668988 |
| 161 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91153982 |
| 162 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90945157 |
| 163 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90801043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.30175595 |
| 2 | MP0003111_abnormal_nucleus_morphology | 4.04047410 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.74748185 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.67371676 |
| 5 | MP0003436_decreased_susceptibility_to | 3.50577441 |
| 6 | MP0003077_abnormal_cell_cycle | 3.43035944 |
| 7 | MP0008057_abnormal_DNA_replication | 3.21370054 |
| 8 | MP0005451_abnormal_body_composition | 3.08139084 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.98733323 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.96577837 |
| 11 | MP0008058_abnormal_DNA_repair | 2.57379230 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.52603726 |
| 13 | MP0005387_immune_system_phenotype | 2.42319114 |
| 14 | MP0001790_abnormal_immune_system | 2.42319114 |
| 15 | MP0005025_abnormal_response_to | 2.39369373 |
| 16 | MP0002419_abnormal_innate_immunity | 2.36797303 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.34216213 |
| 18 | MP0008007_abnormal_cellular_replicative | 2.32268346 |
| 19 | MP0000490_abnormal_crypts_of | 2.24149933 |
| 20 | MP0001545_abnormal_hematopoietic_system | 2.22823659 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 2.22823659 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.13648804 |
| 23 | MP0001730_embryonic_growth_arrest | 2.12869705 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.11343611 |
| 25 | MP0008932_abnormal_embryonic_tissue | 2.10410745 |
| 26 | MP0009278_abnormal_bone_marrow | 2.09599818 |
| 27 | MP0003123_paternal_imprinting | 2.05922094 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 2.05073258 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.93055159 |
| 30 | MP0008260_abnormal_autophagy | 1.92724000 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.91913520 |
| 32 | MP0004947_skin_inflammation | 1.88912005 |
| 33 | MP0000350_abnormal_cell_proliferation | 1.86720073 |
| 34 | MP0003724_increased_susceptibility_to | 1.85858847 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.83386107 |
| 36 | MP0009785_altered_susceptibility_to | 1.83205459 |
| 37 | MP0006082_CNS_inflammation | 1.79670819 |
| 38 | MP0003786_premature_aging | 1.63855042 |
| 39 | MP0002019_abnormal_tumor_incidence | 1.57935683 |
| 40 | MP0001697_abnormal_embryo_size | 1.57042489 |
| 41 | MP0002080_prenatal_lethality | 1.55850888 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.52944526 |
| 43 | MP0003567_abnormal_fetal_cardiomyocyte | 1.51653663 |
| 44 | MP0001672_abnormal_embryogenesis/_devel | 1.50776686 |
| 45 | MP0005380_embryogenesis_phenotype | 1.50776686 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.48973914 |
| 47 | MP0010307_abnormal_tumor_latency | 1.46213192 |
| 48 | MP0002398_abnormal_bone_marrow | 1.45450023 |
| 49 | MP0000685_abnormal_immune_system | 1.45276442 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.44681307 |
| 51 | MP0000313_abnormal_cell_death | 1.44345144 |
| 52 | MP0002085_abnormal_embryonic_tissue | 1.41701654 |
| 53 | MP0002086_abnormal_extraembryonic_tissu | 1.41231961 |
| 54 | MP0010030_abnormal_orbit_morphology | 1.40617302 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.39034174 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.38933072 |
| 57 | MP0002722_abnormal_immune_system | 1.37562929 |
| 58 | MP0003984_embryonic_growth_retardation | 1.36951423 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.33838735 |
| 60 | MP0002088_abnormal_embryonic_growth/wei | 1.33660336 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.31514686 |
| 62 | MP0002084_abnormal_developmental_patter | 1.29314724 |
| 63 | MP0008469_abnormal_protein_level | 1.28623900 |
| 64 | MP0003075_altered_response_to | 1.28480086 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.25018915 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.23218485 |
| 67 | MP0004197_abnormal_fetal_growth/weight/ | 1.22254817 |
| 68 | MP0002132_abnormal_respiratory_system | 1.22151008 |
| 69 | MP0009384_cardiac_valve_regurgitation | 1.19674391 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 1.19419673 |
| 71 | MP0005076_abnormal_cell_differentiation | 1.17255427 |
| 72 | MP0002139_abnormal_hepatobiliary_system | 1.16084566 |
| 73 | MP0002653_abnormal_ependyma_morphology | 1.14192979 |
| 74 | MP0002429_abnormal_blood_cell | 1.12863437 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.12458428 |
| 76 | MP0001293_anophthalmia | 1.09892506 |
| 77 | MP0000343_altered_response_to | 1.08220152 |
| 78 | MP0005023_abnormal_wound_healing | 1.05569512 |
| 79 | MP0006054_spinal_hemorrhage | 1.04289962 |
| 80 | MP0004510_myositis | 1.03026604 |
| 81 | MP0003566_abnormal_cell_adhesion | 1.02359798 |
| 82 | MP0000716_abnormal_immune_system | 1.02212250 |
| 83 | MP0000604_amyloidosis | 1.02070845 |
| 84 | MP0001663_abnormal_digestive_system | 1.01228932 |
| 85 | MP0003941_abnormal_skin_development | 0.99460165 |
| 86 | MP0000358_abnormal_cell_content/ | 0.99459347 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.97753163 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.97689033 |
| 89 | MP0009763_increased_sensitivity_to | 0.97673594 |
| 90 | MP0001145_abnormal_male_reproductive | 0.94796498 |
| 91 | MP0002210_abnormal_sex_determination | 0.94450912 |
| 92 | MP0001849_ear_inflammation | 0.93529293 |
| 93 | MP0001800_abnormal_humoral_immune | 0.92958123 |
| 94 | MP0000858_altered_metastatic_potential | 0.92448715 |
| 95 | MP0005310_abnormal_salivary_gland | 0.91705457 |
| 96 | MP0004381_abnormal_hair_follicle | 0.91482542 |
| 97 | MP0002249_abnormal_larynx_morphology | 0.91289600 |
| 98 | MP0009764_decreased_sensitivity_to | 0.91280651 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.90976662 |
| 100 | MP0003119_abnormal_digestive_system | 0.89046017 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.88553105 |
| 102 | MP0000678_abnormal_parathyroid_gland | 0.88499162 |
| 103 | MP0001851_eye_inflammation | 0.88177191 |
| 104 | MP0002933_joint_inflammation | 0.87739373 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.87279238 |
| 106 | MP0001929_abnormal_gametogenesis | 0.86644224 |
| 107 | MP0002405_respiratory_system_inflammati | 0.86350004 |
| 108 | MP0001853_heart_inflammation | 0.84893428 |
| 109 | MP0002138_abnormal_hepatobiliary_system | 0.83146726 |
| 110 | MP0002420_abnormal_adaptive_immunity | 0.82088407 |
| 111 | MP0000609_abnormal_liver_physiology | 0.81686021 |
| 112 | MP0001873_stomach_inflammation | 0.80095184 |
| 113 | MP0002269_muscular_atrophy | 0.79863574 |
| 114 | MP0001819_abnormal_immune_cell | 0.79544218 |
| 115 | MP0000537_abnormal_urethra_morphology | 0.79170386 |
| 116 | MP0005621_abnormal_cell_physiology | 0.78279453 |
| 117 | MP0002254_reproductive_system_inflammat | 0.78219805 |
| 118 | MP0001915_intracranial_hemorrhage | 0.78184196 |
| 119 | MP0005501_abnormal_skin_physiology | 0.77997864 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.77693227 |
| 121 | MP0005384_cellular_phenotype | 0.77432386 |
| 122 | MP0003828_pulmonary_edema | 0.77342750 |
| 123 | MP0010155_abnormal_intestine_physiology | 0.76855189 |
| 124 | MP0005166_decreased_susceptibility_to | 0.76663479 |
| 125 | MP0002452_abnormal_antigen_presenting | 0.75921818 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.73708520 |
| 127 | MP0004133_heterotaxia | 0.72621763 |
| 128 | MP0005671_abnormal_response_to | 0.72398462 |
| 129 | MP0005464_abnormal_platelet_physiology | 0.72248889 |
| 130 | MP0003091_abnormal_cell_migration | 0.72191100 |
| 131 | MP0001835_abnormal_antigen_presentation | 0.72097284 |
| 132 | MP0003279_aneurysm | 0.71351998 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71169783 |
| 134 | MP0003718_maternal_effect | 0.70504219 |
| 135 | MP0002723_abnormal_immune_serum | 0.70497912 |
| 136 | MP0002111_abnormal_tail_morphology | 0.70215299 |
| 137 | MP0003866_abnormal_defecation | 0.70087878 |
| 138 | MP0003183_abnormal_peptide_metabolism | 0.69602695 |
| 139 | MP0009931_abnormal_skin_appearance | 0.69471750 |
| 140 | MP0005390_skeleton_phenotype | 0.69340737 |
| 141 | MP0000653_abnormal_sex_gland | 0.68857097 |
| 142 | MP0002796_impaired_skin_barrier | 0.68203145 |
| 143 | MP0005165_increased_susceptibility_to | 0.67705899 |
| 144 | MP0002089_abnormal_postnatal_growth/wei | 0.67203123 |
| 145 | MP0005381_digestive/alimentary_phenotyp | 0.66673941 |
| 146 | MP0003795_abnormal_bone_structure | 0.66667041 |
| 147 | MP0008874_decreased_physiological_sensi | 0.66618715 |
| 148 | MP0010630_abnormal_cardiac_muscle | 0.66290506 |
| 149 | MP0004858_abnormal_nervous_system | 0.65942700 |
| 150 | MP0004883_abnormal_blood_vessel | 0.65724858 |
| 151 | MP0004185_abnormal_adipocyte_glucose | 0.65579896 |
| 152 | MP0003303_peritoneal_inflammation | 0.65041883 |
| 153 | MP0008770_decreased_survivor_rate | 0.64975100 |
| 154 | MP0000383_abnormal_hair_follicle | 0.64644743 |
| 155 | MP0002075_abnormal_coat/hair_pigmentati | 0.64477910 |
| 156 | MP0006036_abnormal_mitochondrial_physio | 0.64098268 |
| 157 | MP0008004_abnormal_stomach_pH | 0.64042084 |
| 158 | MP0009840_abnormal_foam_cell | 0.63829619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.64592982 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.43332350 |
| 3 | Reticulocytopenia (HP:0001896) | 4.94711650 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.62548778 |
| 5 | Selective tooth agenesis (HP:0001592) | 3.90840625 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.89914690 |
| 7 | Obstructive lung disease (HP:0006536) | 3.85683385 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 3.85683385 |
| 9 | Cellulitis (HP:0100658) | 3.71603480 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.65211066 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.63627335 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.34184987 |
| 13 | Pallor (HP:0000980) | 3.24259888 |
| 14 | Macrocytic anemia (HP:0001972) | 3.19164156 |
| 15 | Aplastic anemia (HP:0001915) | 3.16961175 |
| 16 | Myositis (HP:0100614) | 3.11653064 |
| 17 | Increased serum ferritin (HP:0003281) | 3.09378992 |
| 18 | Basal cell carcinoma (HP:0002671) | 3.09298101 |
| 19 | Birth length less than 3rd percentile (HP:0003561) | 3.07561993 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.06734483 |
| 21 | Meningitis (HP:0001287) | 3.04768135 |
| 22 | Increased IgE level (HP:0003212) | 3.04631397 |
| 23 | Absent thumb (HP:0009777) | 3.02169764 |
| 24 | Cholecystitis (HP:0001082) | 2.98913876 |
| 25 | Abnormal gallbladder physiology (HP:0012438) | 2.98913876 |
| 26 | Ependymoma (HP:0002888) | 2.98697870 |
| 27 | Thrombocytosis (HP:0001894) | 2.95388747 |
| 28 | Recurrent fungal infections (HP:0002841) | 2.94381794 |
| 29 | Abnormal number of incisors (HP:0011064) | 2.91672175 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 2.91104235 |
| 31 | Purpura (HP:0000979) | 2.91059081 |
| 32 | Oral leukoplakia (HP:0002745) | 2.90123411 |
| 33 | Progressive muscle weakness (HP:0003323) | 2.89413385 |
| 34 | Cerebral aneurysm (HP:0004944) | 2.85569130 |
| 35 | Breast hypoplasia (HP:0003187) | 2.83536013 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.81930232 |
| 37 | Poikiloderma (HP:0001029) | 2.81700310 |
| 38 | Squamous cell carcinoma (HP:0002860) | 2.81171484 |
| 39 | Colon cancer (HP:0003003) | 2.78863244 |
| 40 | Recurrent viral infections (HP:0004429) | 2.78792849 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.76480892 |
| 42 | Recurrent sinusitis (HP:0011108) | 2.74998891 |
| 43 | Gastrointestinal stroma tumor (HP:0100723) | 2.73590901 |
| 44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.67715765 |
| 45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.67715765 |
| 46 | Abnormality of glycolipid metabolism (HP:0010969) | 2.67715765 |
| 47 | IgM deficiency (HP:0002850) | 2.64971416 |
| 48 | Loss of speech (HP:0002371) | 2.64503746 |
| 49 | Hypertensive crisis (HP:0100735) | 2.64263700 |
| 50 | Increased IgM level (HP:0003496) | 2.63619522 |
| 51 | Hepatosplenomegaly (HP:0001433) | 2.61419348 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.59804748 |
| 53 | Trismus (HP:0000211) | 2.57664966 |
| 54 | Reticulocytosis (HP:0001923) | 2.57297148 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.56000691 |
| 56 | Microretrognathia (HP:0000308) | 2.55531567 |
| 57 | Vasculitis (HP:0002633) | 2.53540873 |
| 58 | Colitis (HP:0002583) | 2.52810706 |
| 59 | Neoplasm of the pancreas (HP:0002894) | 2.52654509 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.52129772 |
| 61 | Abnormality of reticulocytes (HP:0004312) | 2.51825228 |
| 62 | Stomatitis (HP:0010280) | 2.51313790 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50869703 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50869703 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50869703 |
| 66 | Gingivitis (HP:0000230) | 2.50713217 |
| 67 | Abnormality of iron homeostasis (HP:0011031) | 2.48154124 |
| 68 | Abnormality of the ileum (HP:0001549) | 2.46821927 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.45932189 |
| 70 | Urticaria (HP:0001025) | 2.45597391 |
| 71 | Rough bone trabeculation (HP:0100670) | 2.43389699 |
| 72 | Premature ovarian failure (HP:0008209) | 2.43025956 |
| 73 | Meckel diverticulum (HP:0002245) | 2.42382161 |
| 74 | Abnormality of the preputium (HP:0100587) | 2.41612527 |
| 75 | Epistaxis (HP:0000421) | 2.41027433 |
| 76 | Vertebral compression fractures (HP:0002953) | 2.40514564 |
| 77 | Myelodysplasia (HP:0002863) | 2.38557512 |
| 78 | Mucopolysacchariduria (HP:0008155) | 2.37486519 |
| 79 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37486519 |
| 80 | Patellar aplasia (HP:0006443) | 2.36584119 |
| 81 | Supernumerary spleens (HP:0009799) | 2.36429443 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.36035707 |
| 83 | Fatigue (HP:0012378) | 2.35695041 |
| 84 | Recurrent skin infections (HP:0001581) | 2.34183727 |
| 85 | Petechiae (HP:0000967) | 2.33877941 |
| 86 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.33723223 |
| 87 | Chromsome breakage (HP:0040012) | 2.33553251 |
| 88 | Premature graying of hair (HP:0002216) | 2.32420602 |
| 89 | Orchitis (HP:0100796) | 2.31539040 |
| 90 | Nasal polyposis (HP:0100582) | 2.29650268 |
| 91 | Polycythemia (HP:0001901) | 2.28797977 |
| 92 | Emphysema (HP:0002097) | 2.28461984 |
| 93 | Asplenia (HP:0001746) | 2.27430390 |
| 94 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.26765930 |
| 95 | Pustule (HP:0200039) | 2.25854322 |
| 96 | Carpal bone hypoplasia (HP:0001498) | 2.25581009 |
| 97 | Medulloblastoma (HP:0002885) | 2.25054226 |
| 98 | Proximal placement of thumb (HP:0009623) | 2.24796730 |
| 99 | Abnormality of the nasal mucosa (HP:0000433) | 2.23879573 |
| 100 | Chest pain (HP:0100749) | 2.23804428 |
| 101 | Panhypogammaglobulinemia (HP:0003139) | 2.22082311 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21712237 |
| 103 | Absent radius (HP:0003974) | 2.21569586 |
| 104 | Inflammation of the large intestine (HP:0002037) | 2.21280383 |
| 105 | Granulocytopenia (HP:0001913) | 2.20567126 |
| 106 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.20460325 |
| 107 | Hypergammaglobulinemia (HP:0010702) | 2.20235964 |
| 108 | Spontaneous hematomas (HP:0007420) | 2.19606423 |
| 109 | Degeneration of anterior horn cells (HP:0002398) | 2.16434524 |
| 110 | Abnormality of the anterior horn cell (HP:0006802) | 2.16434524 |
| 111 | Polygenic inheritance (HP:0010982) | 2.14811039 |
| 112 | Increased connective tissue (HP:0009025) | 2.13555486 |
| 113 | Abnormality of DNA repair (HP:0003254) | 2.13281658 |
| 114 | Tracheoesophageal fistula (HP:0002575) | 2.12351150 |
| 115 | Tongue fasciculations (HP:0001308) | 2.11382780 |
| 116 | Pancytopenia (HP:0001876) | 2.11219074 |
| 117 | Small intestinal stenosis (HP:0012848) | 2.10811563 |
| 118 | Duodenal stenosis (HP:0100867) | 2.10811563 |
| 119 | Abnormality of chromosome stability (HP:0003220) | 2.10791186 |
| 120 | Lymphoma (HP:0002665) | 2.09225538 |
| 121 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.08537511 |
| 122 | Osteomyelitis (HP:0002754) | 2.07176263 |
| 123 | Deviation of the thumb (HP:0009603) | 2.05236059 |
| 124 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.04211335 |
| 125 | Mesangial abnormality (HP:0001966) | 2.03590729 |
| 126 | Aplasia involving forearm bones (HP:0009822) | 2.02948818 |
| 127 | Absent forearm bone (HP:0003953) | 2.02948818 |
| 128 | Prominent nose (HP:0000448) | 2.02580878 |
| 129 | Abnormality of the peritoneum (HP:0002585) | 2.01461951 |
| 130 | Acute hepatic failure (HP:0006554) | 2.00864615 |
| 131 | Muscle fibrillation (HP:0010546) | 2.00619229 |
| 132 | Lymphopenia (HP:0001888) | 1.99957406 |
| 133 | Restrictive lung disease (HP:0002091) | 1.98751822 |
| 134 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98733006 |
| 135 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98733006 |
| 136 | Encephalitis (HP:0002383) | 1.98689344 |
| 137 | Hypertriglyceridemia (HP:0002155) | 1.98672326 |
| 138 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98435000 |
| 139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98210448 |
| 140 | Interstitial pulmonary disease (HP:0006530) | 1.96986572 |
| 141 | Ragged-red muscle fibers (HP:0003200) | 1.96593752 |
| 142 | Bone marrow hypocellularity (HP:0005528) | 1.96356002 |
| 143 | J-shaped sella turcica (HP:0002680) | 1.96167296 |
| 144 | Abnormality of lateral ventricle (HP:0030047) | 1.95907856 |
| 145 | Distal lower limb muscle weakness (HP:0009053) | 1.95572044 |
| 146 | Skin rash (HP:0000988) | 1.95130521 |
| 147 | Esophageal atresia (HP:0002032) | 1.94062125 |
| 148 | Agnosia (HP:0010524) | 1.94042111 |
| 149 | Hyperacusis (HP:0010780) | 1.93258946 |
| 150 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92256515 |
| 151 | Skin ulcer (HP:0200042) | 1.91582005 |
| 152 | Chronic otitis media (HP:0000389) | 1.91204149 |
| 153 | Pulmonary infiltrates (HP:0002113) | 1.90861874 |
| 154 | Acute lymphatic leukemia (HP:0006721) | 1.90525615 |
| 155 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.89868673 |
| 156 | Achilles tendon contracture (HP:0001771) | 1.89392822 |
| 157 | Cellular immunodeficiency (HP:0005374) | 1.88749495 |
| 158 | Impaired platelet aggregation (HP:0003540) | 1.86493545 |
| 159 | Abnormal platelet function (HP:0011869) | 1.86493545 |
| 160 | Amaurosis fugax (HP:0100576) | 1.86448541 |
| 161 | Hypochromic anemia (HP:0001931) | 1.85084851 |
| 162 | Multiple enchondromatosis (HP:0005701) | 1.84829709 |
| 163 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.84668375 |
| 164 | Cerebral hypomyelination (HP:0006808) | 1.84145515 |
| 165 | Increased nuchal translucency (HP:0010880) | 1.83862056 |
| 166 | Rib fusion (HP:0000902) | 1.83559523 |
| 167 | Cerebral palsy (HP:0100021) | 1.83489990 |
| 168 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.83002501 |
| 169 | Glioma (HP:0009733) | 1.81916430 |
| 170 | Progressive neurologic deterioration (HP:0002344) | 1.81715660 |
| 171 | Biconcave vertebral bodies (HP:0004586) | 1.81132418 |
| 172 | Hypoplasia of the pons (HP:0012110) | 1.79486404 |
| 173 | Atresia of the external auditory canal (HP:0000413) | 1.79315946 |
| 174 | Cafe-au-lait spot (HP:0000957) | 1.78616041 |
| 175 | Abnormality of the duodenum (HP:0002246) | 1.78004918 |
| 176 | Sloping forehead (HP:0000340) | 1.77810148 |
| 177 | Slender long bone (HP:0003100) | 1.77689141 |
| 178 | Neoplasm of the colon (HP:0100273) | 1.77652715 |
| 179 | Rhabdomyosarcoma (HP:0002859) | 1.77095964 |
| 180 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.76670533 |
| 181 | Neoplasm of the oral cavity (HP:0100649) | 1.76634626 |
| 182 | Bowel diverticulosis (HP:0005222) | 1.74910085 |
| 183 | 11 pairs of ribs (HP:0000878) | 1.73760489 |
| 184 | Hypoplasia of the radius (HP:0002984) | 1.73719492 |
| 185 | Skin tags (HP:0010609) | 1.72330985 |
| 186 | Preauricular skin tag (HP:0000384) | 1.72026727 |
| 187 | High pitched voice (HP:0001620) | 1.71154949 |
| 188 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.69923155 |
| 189 | Duplicated collecting system (HP:0000081) | 1.68574605 |
| 190 | Short thumb (HP:0009778) | 1.68439960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.97301447 |
| 2 | WEE1 | 3.68123557 |
| 3 | MAP3K10 | 3.27502285 |
| 4 | RIPK4 | 3.10197618 |
| 5 | EEF2K | 2.91219295 |
| 6 | SMG1 | 2.83030020 |
| 7 | PRPF4B | 2.66626358 |
| 8 | NEK2 | 2.63372735 |
| 9 | MAP3K13 | 2.41032564 |
| 10 | CDC7 | 2.40827079 |
| 11 | TTK | 2.33025571 |
| 12 | RPS6KB2 | 2.28600168 |
| 13 | NME2 | 2.20006258 |
| 14 | MAP4K1 | 2.12549035 |
| 15 | STK10 | 1.94992048 |
| 16 | IRAK3 | 1.93915934 |
| 17 | DYRK3 | 1.76838161 |
| 18 | MAP3K14 | 1.76189062 |
| 19 | CDK7 | 1.71303138 |
| 20 | IRAK4 | 1.71269789 |
| 21 | PKN2 | 1.68871537 |
| 22 | PIM2 | 1.68063043 |
| 23 | PLK1 | 1.66084807 |
| 24 | FLT3 | 1.64439565 |
| 25 | SIK1 | 1.64177747 |
| 26 | ZAK | 1.63686280 |
| 27 | KDR | 1.61105545 |
| 28 | VRK2 | 1.60819895 |
| 29 | CDK12 | 1.58259248 |
| 30 | FES | 1.57773707 |
| 31 | CDK4 | 1.52572752 |
| 32 | TAOK1 | 1.50682890 |
| 33 | MAP3K11 | 1.50313968 |
| 34 | SCYL2 | 1.46379178 |
| 35 | MAPKAPK3 | 1.46182243 |
| 36 | MAP3K1 | 1.43230730 |
| 37 | ACVR1B | 1.43130219 |
| 38 | PASK | 1.41994478 |
| 39 | ATR | 1.41640747 |
| 40 | MATK | 1.41159773 |
| 41 | TESK2 | 1.40444631 |
| 42 | TNK2 | 1.39881841 |
| 43 | MAP3K8 | 1.38862060 |
| 44 | TSSK6 | 1.37438281 |
| 45 | BRSK2 | 1.36618955 |
| 46 | MAP3K3 | 1.34789458 |
| 47 | TRIB3 | 1.34152412 |
| 48 | AURKB | 1.32090519 |
| 49 | LRRK2 | 1.31089309 |
| 50 | FGFR4 | 1.30689438 |
| 51 | PAK4 | 1.30491621 |
| 52 | NEK1 | 1.29065253 |
| 53 | EPHA2 | 1.26814107 |
| 54 | TGFBR1 | 1.26179299 |
| 55 | STK16 | 1.24947873 |
| 56 | VRK1 | 1.23602007 |
| 57 | EPHB1 | 1.23002190 |
| 58 | ICK | 1.17991791 |
| 59 | CHEK2 | 1.17929458 |
| 60 | AURKA | 1.14867730 |
| 61 | RPS6KA4 | 1.14844773 |
| 62 | EIF2AK1 | 1.13276885 |
| 63 | ERN1 | 1.12366182 |
| 64 | PIM1 | 1.10991638 |
| 65 | BCKDK | 1.10216276 |
| 66 | IKBKE | 1.05683131 |
| 67 | IKBKB | 1.05624608 |
| 68 | SYK | 1.05063883 |
| 69 | EIF2AK3 | 0.98365757 |
| 70 | SRPK1 | 0.97211511 |
| 71 | HCK | 0.97138131 |
| 72 | GRK6 | 0.95728695 |
| 73 | PLK4 | 0.92347340 |
| 74 | MAP3K7 | 0.87927585 |
| 75 | BRSK1 | 0.87198489 |
| 76 | TLK1 | 0.86760604 |
| 77 | CHEK1 | 0.86419771 |
| 78 | CDC42BPA | 0.85273162 |
| 79 | STK4 | 0.85039453 |
| 80 | TESK1 | 0.84514124 |
| 81 | ZAP70 | 0.82991767 |
| 82 | MAP2K3 | 0.81059675 |
| 83 | MKNK1 | 0.80077272 |
| 84 | BTK | 0.80028637 |
| 85 | LYN | 0.78029049 |
| 86 | SIK2 | 0.77755057 |
| 87 | PAK2 | 0.76895838 |
| 88 | MAP2K2 | 0.73550946 |
| 89 | TTN | 0.73174540 |
| 90 | PRKD2 | 0.71350094 |
| 91 | IRAK2 | 0.70973656 |
| 92 | PDPK1 | 0.69561149 |
| 93 | RIPK1 | 0.68052346 |
| 94 | MTOR | 0.68011182 |
| 95 | ARAF | 0.66486297 |
| 96 | CLK1 | 0.66398769 |
| 97 | CDK2 | 0.66173181 |
| 98 | CSF1R | 0.66166581 |
| 99 | KSR2 | 0.66051157 |
| 100 | ITK | 0.65691103 |
| 101 | HIPK2 | 0.65423870 |
| 102 | PAK1 | 0.65259858 |
| 103 | MARK2 | 0.64900799 |
| 104 | MAPK15 | 0.63400355 |
| 105 | CDK19 | 0.63076712 |
| 106 | CDK6 | 0.62531952 |
| 107 | DYRK1B | 0.62207975 |
| 108 | BMX | 0.61691198 |
| 109 | SIK3 | 0.61223089 |
| 110 | FGR | 0.60975057 |
| 111 | ATM | 0.60066814 |
| 112 | KIT | 0.59897933 |
| 113 | CCNB1 | 0.59195414 |
| 114 | CSNK2A2 | 0.58892834 |
| 115 | AKT2 | 0.58448692 |
| 116 | PLK3 | 0.58064688 |
| 117 | MAPK11 | 0.57860315 |
| 118 | JAK1 | 0.56714877 |
| 119 | IRAK1 | 0.56491254 |
| 120 | JAK2 | 0.55586749 |
| 121 | CSNK2A1 | 0.52983469 |
| 122 | ALK | 0.52346316 |
| 123 | TYK2 | 0.51681426 |
| 124 | PDK1 | 0.50428357 |
| 125 | MAPK12 | 0.50328277 |
| 126 | DAPK3 | 0.49214175 |
| 127 | TAOK2 | 0.49124367 |
| 128 | TBK1 | 0.45111354 |
| 129 | RAF1 | 0.44001180 |
| 130 | DAPK1 | 0.43992943 |
| 131 | BRAF | 0.43048123 |
| 132 | PTK6 | 0.42970144 |
| 133 | JAK3 | 0.42930031 |
| 134 | PRKG2 | 0.42620452 |
| 135 | MAP3K6 | 0.42306941 |
| 136 | BLK | 0.42042248 |
| 137 | MAPKAPK2 | 0.41745037 |
| 138 | TEC | 0.41434570 |
| 139 | ILK | 0.40543632 |
| 140 | MARK3 | 0.40190818 |
| 141 | CDK9 | 0.40082919 |
| 142 | CSK | 0.39090875 |
| 143 | PRKCI | 0.37792456 |
| 144 | CDK1 | 0.37641442 |
| 145 | RPS6KA2 | 0.37590788 |
| 146 | ABL2 | 0.36508582 |
| 147 | RPS6KC1 | 0.35012993 |
| 148 | RPS6KL1 | 0.35012993 |
| 149 | RPS6KA6 | 0.34360934 |
| 150 | BRD4 | 0.33664283 |
| 151 | CHUK | 0.32447256 |
| 152 | RPS6KA5 | 0.31967843 |
| 153 | LCK | 0.31746277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.97562293 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.19218267 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.98893646 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.26791361 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 3.19447364 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.16740886 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 3.03062842 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.86101768 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.78851076 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.74030742 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.68443401 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.62014991 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58168079 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 2.54260213 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.43365070 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.41934215 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.34547903 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 2.33711494 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 2.30885208 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.26039260 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.17496472 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.12875051 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12381677 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.09954900 |
| 25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.04642396 |
| 26 | p53 signaling pathway_Homo sapiens_hsa04115 | 2.03304840 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.95237460 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83279927 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78572656 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73831468 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64845744 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.58398146 |
| 33 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.51469089 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.45985731 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.41514602 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.40812813 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38409585 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.30452325 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29733525 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.29388825 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18661846 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.16571096 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16408288 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16142855 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.11164657 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.07877229 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07168534 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.06854467 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06468001 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06045104 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05602560 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03904084 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00660990 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00561633 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.00248783 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99671198 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98765326 |
| 58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98246126 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97286235 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 0.96657882 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.90252642 |
| 62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88968585 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.87946707 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87875602 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87005493 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86916401 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86367904 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85795001 |
| 69 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.85374564 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84286098 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83414690 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83207243 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83079667 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83038403 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81689136 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.79356406 |
| 77 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.73634451 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.70688200 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69257638 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68356406 |
| 81 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68329501 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67878563 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67611717 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.67513272 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66768226 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.66707669 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65987968 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65525678 |
| 89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65455335 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.64129939 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.63806136 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.62194690 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61482639 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61243476 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58527924 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57934064 |
| 97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57109837 |
| 98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55387985 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55229524 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54985018 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53032395 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52183514 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51722436 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50987881 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50746925 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50685159 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50338779 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49066911 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48774696 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48464777 |
| 111 | Measles_Homo sapiens_hsa05162 | 0.48412121 |
| 112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47867821 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.45319066 |
| 114 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44766308 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43881327 |
| 116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43451429 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40381674 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.39889064 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38966894 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38812595 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37870369 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37024406 |
| 123 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35963850 |
| 124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.35869818 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.35554442 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.35030684 |
| 127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34728475 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34421769 |
| 129 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32685757 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.31916675 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30404465 |
| 132 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30159630 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29676434 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29571081 |
| 135 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28155670 |
| 136 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27679482 |
| 137 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26877827 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26466008 |
| 139 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24970898 |
| 140 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24080908 |
| 141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23348821 |
| 142 | Influenza A_Homo sapiens_hsa05164 | 0.21942647 |
| 143 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20381261 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20295666 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20026300 |
| 146 | Alcoholism_Homo sapiens_hsa05034 | 0.17469959 |
| 147 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.16476880 |
| 148 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.16124148 |
| 149 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.15997362 |

